Results 161 to 170 of about 683,284 (269)
CDC7 is a targetable regulator of advanced prostate cancer. [PDF]
Hartono AB +6 more
europepmc +1 more source
Impact of Abdominal/Pelvic Surgery on Late Rectal Bleeding and Increased Stool Frequency/tenesmus After Prostate Cancer High-dose 3DCRT [PDF]
V. Vavassori +9 more
openalex +1 more source
Retinoic Acid Reprograms Mast Cells Toward a Proinflammatory State to Enhance Antitumor Immunity
Proinflammatory mast cells represent an MHC‐IIhigh, cytokine‐producing mast cell subset associated with improved survival and enhanced responses to anti‐PD‐1 therapy. Retinoic acid drives their polarization, enabling antigen uptake and presentation, and T cell recruitment and activation, collectively promoting adaptive anti‐tumor immunity.
Lizao Zhang +25 more
wiley +1 more source
Prostate Cancer Screening: Evidence, Ethics, and Reframing Education. [PDF]
Takahashi T.
europepmc +1 more source
A Radiobiological Perspective between IMRT and 3D Conformal Treatment of Prostate Cancer [PDF]
S Stathakis +7 more
openalex +1 more source
This study shows anti‐CEACAM5 CAR T‐cells are ineffective against colorectal cancer (CRC) because of CEACAM5 sequestration at intercellular junctions and the thick tumour cell glycocalyx. Enzymatic treatments of CRC cell monolayer/tissue section with trypsin or hyaluronidase restore CEACAM5 availability, enhance CAR T‐cell activation, increase ...
Debasis Banik +13 more
wiley +1 more source
Neoadjuvant Therapies for Prostate Cancer-Current Paradigms and Future Directions. [PDF]
Sandhu K +9 more
europepmc +1 more source
This study reveals that the E3 ubiquitin ligase TRIM56 exacerbates neuronal ferroptosis and brain damage by mediating K48‐linked ubiquitination and degradation of KLF4, leading to suppression of the xCT/GSH/GPX4 axis. Targeting TRIM56 alleviates cerebral ischemia‐reperfusion injury in vivo and in vitro, highlighting its therapeutic potential.
Qiangping Wang +15 more
wiley +1 more source

